Gene Page: GOLGA2P5
Summary ?
| GeneID | 55592 |
| Symbol | GOLGA2P5 |
| Synonyms | GOLGA2B|GOLGA2L1 |
| Description | golgin A2 pseudogene 5 |
| Reference | HGNC:HGNC:25315|Ensembl:ENSG00000238105|HPRD:13195| |
| Gene type | pseudo |
| Map location | 12q23.1 |
| Pascal p-value | 0.064 |
| Fetal beta | 0.342 |
Gene in Data Sources
| Gene set name | Method of gene set | Description | Info |
|---|---|---|---|
| CV:GWASdb | Genome-wide Association Studies | GWASdb records for schizophrenia | |
| CV:PGCnp | Genome-wide Association Study | GWAS |
Section I. Genetics and epigenetics annotation
Section II. Transcriptome annotation
General gene expression (GTEx)
Gene expression during devlopment (BrainCloud)
Footnote:
A total of 269 time points ploted, with n=38 fetal samples (x=1:38). Each triangle represents one time point.
Gene expression of temporal and spatial changes (BrainSpan)
Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes the lower 25% and upper 25% of the expression distribution.
Top co-expressed genes in brain regions
| Top 10 positively co-expressed genes | ||
| Gene | Pearson's Correlation | Spearman's Correlation |
| PTPN3 | 0.89 | 0.44 |
| FAM19A4 | 0.89 | 0.66 |
| RGS16 | 0.89 | 0.30 |
| SUSD2 | 0.88 | 0.72 |
| TTC39A | 0.86 | 0.59 |
| GNG13 | 0.86 | 0.54 |
| TANC1 | 0.86 | 0.70 |
| NPL | 0.86 | 0.59 |
| RASSF3 | 0.84 | 0.47 |
| EPN3 | 0.84 | 0.43 |
| Top 10 negatively co-expressed genes | ||
| Gene | Pearson's Correlation | Spearman's Correlation |
| PLEKHO1 | -0.41 | -0.72 |
| NR2C2AP | -0.39 | -0.75 |
| WDR86 | -0.38 | -0.51 |
| EMID1 | -0.37 | -0.61 |
| TUBB2B | -0.35 | -0.71 |
| AC009133.1 | -0.34 | -0.64 |
| YPEL1 | -0.34 | -0.59 |
| C19orf57 | -0.34 | -0.60 |
| SHF | -0.34 | -0.60 |
| KIAA1949 | -0.34 | -0.65 |
Section V. Pathway annotation
| Pathway name | Pathway size | # SZGR 2.0 genes in pathway | Info |
|---|---|---|---|
| BASAKI YBX1 TARGETS DN | 384 | 230 | All SZGR 2.0 genes in this pathway |
| ZHOU INFLAMMATORY RESPONSE FIMA DN | 284 | 156 | All SZGR 2.0 genes in this pathway |
| DODD NASOPHARYNGEAL CARCINOMA UP | 1821 | 933 | All SZGR 2.0 genes in this pathway |
| PEREZ TP53 TARGETS | 1174 | 695 | All SZGR 2.0 genes in this pathway |
| PEREZ TP63 TARGETS | 355 | 243 | All SZGR 2.0 genes in this pathway |
| PEREZ TP53 AND TP63 TARGETS | 205 | 145 | All SZGR 2.0 genes in this pathway |
| CREIGHTON ENDOCRINE THERAPY RESISTANCE 2 | 473 | 224 | All SZGR 2.0 genes in this pathway |
| SMID BREAST CANCER RELAPSE IN BRAIN DN | 85 | 58 | All SZGR 2.0 genes in this pathway |
| SMID BREAST CANCER BASAL DN | 701 | 446 | All SZGR 2.0 genes in this pathway |
| POOLA INVASIVE BREAST CANCER DN | 134 | 83 | All SZGR 2.0 genes in this pathway |